Paradoxically, DKC1 overexpression correlates with disease progression and poor prognosis in many sporadic cancers, such as prostate and breast tumors, and DKC1 levels also associate with higher levels of TERC expression and telomerase activity in some of these tumors. This evidence concerns the gene TERC and breast neoplasm.